Decoy Therapeutics Inc.
DCOY
$2.99
$0.010.34%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.37M | -2.22M | -8.98M | -873.50K | -957.80K |
| Total Depreciation and Amortization | 13.60K | 5.90K | 3.80K | 1.10K | 1.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 206.20K | 213.00K | 8.65M | 22.80K | 23.20K |
| Change in Net Operating Assets | -498.00K | -883.70K | -813.60K | -797.20K | 71.30K |
| Cash from Operations | -2.65M | -2.89M | -1.14M | -1.65M | -862.30K |
| Capital Expenditure | -42.40K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 964.70K | -200.00K | -- |
| Cash from Investing | -42.40K | -- | 964.70K | -200.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | -112.20K |
| Issuance of Common Stock | 3.16M | -- | 6.07M | 5.86M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -29.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.16M | -- | 6.07M | 5.86M | -141.20K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 468.50K | -2.89M | 5.90M | 4.01M | -1.00M |